@VPrasadMDMPH I agree this is plausible. There are obvious parallels between overeating and addictions to alcohol and drugs. GLP-1R agonists have been suggested to have a broad effect on reducing addictive behaviours (eg. below). https://t.co/m23DBtBftJ
The role of glucagon-like peptide 1 (GLP-1) in addictive disorders.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Jan 2021 – Oct 2025Where it's discussed
-
News119 articles
-
X / Twitter29 posts
-
Blogs12 articles
-
Bluesky2 posts
-
YouTube2 videos
-
Facebook2 posts
AI synopsis
What people are saying
The discussions reveal a keen interest in the emerging research on GLP-1’s role in addiction, with posts citing recent publications, mechanisms involving dopamine pathways, and the therapeutic promise of medications like Ozempic. The tone varies from enthusiastic praise—calling it 'psychiatry’s secret weapon'—to more cautious notes about mechanisms still being investigated, illustrating a mix of optimism and critical curiosity that enriches the overall conversation.
Most discussions acknowledge the promising role of GLP-1 in addiction treatment, with several posts referencing research evidence and therapeutic potential.
The posts demonstrate high curiosity, referencing new research, mechanisms, potential applications, and even celebrity influence, indicating strong engagement with the topic.
Many discussions go beyond superficial mentions, including mentions of mechanisms, clinical trials, and calls for further exploration, reflecting deep engagement.
Posts generally see GLP-1 research as impactful, discussing its potential to revolutionize addiction and mental health treatment, though some skepticism remains.
Abstract in brief
- Glucagonlike peptide 1 (GLP1) plays a potential role in treating addiction, including alcohol and tobacco use disorders, by reducing drug intake and craving.
- Research in animals and early clinical trials suggest that GLP1 receptor agonists, which are already used for diabetes and obesity, might help decrease substance use possibly by affecting dopamine pathways in the brain.
- While promising, the exact mechanisms of how GLP1 influences addictive behaviors are still being studied, but it is believed to involve central nervous system effects related to dopamine signaling.]
Top posts
Most liked on X and BlueskyThe role of glucagon‐like peptide 1 (GLP‐1) in addictive disorders https://t.co/3bFOqGmeLn
@vijaypande There's solid evidence that GLP-1 inhibitors do affect addictive behaviors. Here's a paper: https://t.co/NIhdu50hkk
New Research: Can GLP-1 Be a Target for Reward System Related Disorders? A Qualitative Synthesis and Systematic Review Analysis of Studies on Palatable Food, Drugs of Abuse, and Alcohol: The role of glucagon-like peptide 1 (GLP-1) in… https://t.co/6s1EXay1Wx #neuroscience
@yash_adroja @thehouseofpod @DrNadolsky @DrKarlNadolsky came here to say this i could also talk about it from the psych point of view where we have seen amazing results and different utilizations
@therealRYC @nplusyears @JAMAPsych Made a video on the topic a bit ago (need to make a new thumbnail haha) Long and short, no need to adjust dosing either. Work them independently. Can My Psychiatrist Prescribe Ozempic? | Ozempic And Mental Health https://t.co/6jqEe8L8UP
All mentions
Potential of Ozempic for Mental Health and Addiction Treatment
To learn more about Ozempic and mental health and whether my psychiatrist can prescribe Ozempic please visit our YouTube channel. The video explores how Ozempic may impact mental wellness, substance use, and weight…
Exploring Ozempic's Role in Obesity Treatment and Industry Promises
In this video, we discuss the use of weight-loss injections and their potential to revolutionize obesity treatment versus industry-promoted promises. We examine scientific insights on GLP-1 hormones and recent research…
@therealRYC @nplusyears @JAMAPsych Made a video on the topic a bit ago (need to make a new thumbnail haha) Long and short, no need to adjust dosing either. Work them independently. Can My Psychiatrist Prescribe Ozempic? | Ozempic And Mental Health https://t.co/6jqEe8L8UP
What you need to know on the "Role of Glucagon-Like Peptide-1 Receptor Agonists in People With Infertility and Pregnancy" -- read now at ow.ly/Ywno50V9FhU
An analysis on the role of glucagon-like peptide-1 receptor agonists in cognitive and mental .. - goo.gl/alerts/qmw8HR #GoogleAlerts
RT @dextrodexter: @vijaypande That been said, there’s more to investigated about the mechanism. I posit this interaction occurs at the casc…
@yash_adroja @thehouseofpod @DrNadolsky @DrKarlNadolsky came here to say this i could also talk about it from the psych point of view where we have seen amazing results and different utilizations
Tons of negative attention on Ozempic, while silent on the other 7 FDA approved weight loss medications. Is it the fact GLP-1s like Ozempic are being studied as potential drug & alcohol anti-addiction treatments or the fact celebrities are misusing them. https://t.co/74ac0yWZ8k https://t.co/4VDjLZ4ga1
@RecoveryDoctor @rogersmcintyre Yeah my initial version of the tweet was medicine instead of psychiatry. I call it the biggest advancement in medicine since Viagra in my video I did on it a little while ago. Why Ozempic Is Psychiatry's SECRET Weapon! https://t.co/6jqEe8L8UP
https://t.co/zfyWSoqXaU
@l_oshman @MWeintraubMD https://t.co/Kw4UucftEm
@chagataikhante @oozn GLP-1'in alkol ve madde kullanım bozukluklarındaki etkilerine merkezi olarak, en azından kısmen dopamin sinyali yoluyla aracılık edildiğini, ancak kesin mekanizmaların hala ortaya çıkarılmadığını öne sürüyoruz. https://t.co/xpTDzTkDa5
Ozempic, Wegovy, Mounjaro - GLP-1 Agonists for Addiction? This is just hitting the mainstream headlines now, but there has been research on non-human models on substance abuse disorders and the role of GLP-1 in reducing addiction for years now. https://t.co/GRo3aCGhIX
@vijaypande That been said, there’s more to investigated about the mechanism. I posit this interaction occurs at the cascading level because both GLP-1 and dopamine patronize cyclic AMP and it’s associates. More info here in this publication
RT @k_salberta: @vijaypande There's solid evidence that GLP-1 inhibitors do affect addictive behaviors. Here's a paper: https://t.co/NIhdu5…
RT @BallouxFrancois: @VPrasadMDMPH I agree this is plausible. There are obvious parallels between overeating and addictions to alcohol and…
RT @k_salberta: @vijaypande There's solid evidence that GLP-1 inhibitors do affect addictive behaviors. Here's a paper: https://t.co/NIhdu5…
RT @BallouxFrancois: @VPrasadMDMPH I agree this is plausible. There are obvious parallels between overeating and addictions to alcohol and…
@VPrasadMDMPH I agree this is plausible. There are obvious parallels between overeating and addictions to alcohol and drugs. GLP-1R agonists have been suggested to have a broad effect on reducing addictive behaviours (eg. below). https://t.co/m23DBtBftJ
@vijaypande There's solid evidence that GLP-1 inhibitors do affect addictive behaviors. Here's a paper: https://t.co/NIhdu50hkk
RT @CMichaelGibson: The role of glucagon‐like peptide 1 (GLP‐1) in addictive disorders https://t.co/3bFOqGmeLn
@hubermanlab Hi! I'd love your take on this. Perhaps a deep-dive podcast? So interesting and so much potential! https://t.co/t6CsgBLjCq.
RT @CMichaelGibson: The role of glucagon‐like peptide 1 (GLP‐1) in addictive disorders https://t.co/3bFOqGmeLn
RT @CMichaelGibson: The role of glucagon‐like peptide 1 (GLP‐1) in addictive disorders https://t.co/3bFOqGmeLn
RT @CMichaelGibson: The role of glucagon‐like peptide 1 (GLP‐1) in addictive disorders https://t.co/3bFOqGmeLn
RT @CMichaelGibson: The role of glucagon‐like peptide 1 (GLP‐1) in addictive disorders https://t.co/3bFOqGmeLn
The role of glucagon‐like peptide 1 (GLP‐1) in addictive disorders https://t.co/3bFOqGmeLn
The role of glucagon‐like peptide 1 (GLP‐1) in addictive disorders https://t.co/IpNAFDB0ha
RT @FrontNeurosci: New Research: Can GLP-1 Be a Target for Reward System Related Disorders? A Qualitative Synthesis and Systematic Review A…
RT @FrontNeurosci: New Research: Can GLP-1 Be a Target for Reward System Related Disorders? A Qualitative Synthesis and Systematic Review A…
RT @FrontNeurosci: New Research: Can GLP-1 Be a Target for Reward System Related Disorders? A Qualitative Synthesis and Systematic Review A…
RT @FrontNeurosci: New Research: Can GLP-1 Be a Target for Reward System Related Disorders? A Qualitative Synthesis and Systematic Review A…
New Research: Can GLP-1 Be a Target for Reward System Related Disorders? A Qualitative Synthesis and Systematic Review Analysis of Studies on Palatable Food, Drugs of Abuse, and Alcohol: The role of glucagon-like peptide 1 (GLP-1) in… https://t.co/6s1EXay1Wx #neuroscience